|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/5355 | (2006.01) |
| A61P 37/00 | (2006.01) | ||
| A61P 37/06 | (2006.01) | ||
| A61K 31/5377 | (2006.01) |
| (11) | Number of the document | 2882441 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13752753.7 |
| Date of filing the European patent application | 2013-08-08 | |
| (97) | Date of publication of the European application | 2015-06-17 |
| (45) | Date of publication and mention of the grant of the patent | 2020-04-29 |
| (46) | Date of publication of the claims translation | 2020-07-27 |
| (86) | Number | PCT/US2013/054051 |
| Date | 2013-08-08 |
| (87) | Number | WO 2014/025958 |
| Date | 2014-02-13 |
| (30) | Number | Date | Country code |
| 201261681491 P | 2012-08-09 | US | |
| 201261722718 P | 2012-11-05 | US |
| (72) |
SCHAFER, Peter, H., US
CHOPRA, Rajesh, GB
GANDHI, Anita, US
|
| (73) |
Celgene Corporation,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Su imunitetu susijusių ir uždegiminių ligų gydymas |
| TREATMENT OF IMMUNE-RELATED AND INFLAMMATORY DISEASES |
| Payment date | Validity (years) | Amount | |
| 2025-07-03 | 13 | 289.00 EUR |
| 2026-08-08 |